Schiller; Peter W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schiller; Peter W..The latest application filed is for "methods for preventing or treating mitochondrial permeability transition".

Company Profile

2.10.19

Schiller; Peter W. - Montreal CA
Schiller, Peter W - Quebec CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Preventing Or Treating Mitochondrial Permeability Transition App 20200038472 - Szeto; Hazel H. ; et al.	2020-02-06
Aromatic-cationic Peptides And Uses Of Same App 20190330272 - SZETO; Hazel H. ; et al.	2019-10-31
Aromatic-cationic Peptides And Uses Of Same App 20180244721 - SZETO; Hazel H. ; et al.	2018-08-30
Aromatic-cationic Peptides And Uses Of Same App 20170008925 - SZETO; Hazel H. ; et al.	2017-01-12
Methods For Preventing Or Treating Mitochondrial Permeability Transition App 20150359838 - Szeto; Hazel H. ; et al.	2015-12-17
Methods for preventing or treating mitochondrial permeability transition Grant 8,957,030 - Szeto , et al. February 17, 2	2015-02-17
Aromatic-cationic Peptides And Uses Of Same App 20150005242 - SZETO; Hazel H. ; et al.	2015-01-01
Aromatic-cationic Peptides And Uses Of Same App 20130316964 - SZETO; Hazel H. ; et al.	2013-11-28
Methods For Preventing Or Treating Mitochondrial Permeability Transition App 20130244957 - Szeto; Hazel H. ; et al.	2013-09-19
Methods for preventing or treating mitochondrial permeability transition Grant 8,404,646 - Schiller , et al. March 26, 2	2013-03-26
Aromatic-cationic Peptides And Uses Of Same App 20120329730 - Szeto; Hazel H. ; et al.	2012-12-27
Methods For Preventing Or Treating Mitochondrial Permeability Transition App 20120021970 - Schiller; Peter W. ; et al.	2012-01-26
Methods For Preventing Or Treating Mitochondrial Permeability Transition App 20100190718 - Schiller; Peter W. ; et al.	2010-07-29
Medicinal uses of mu-opioid receptor agonists Grant 7,732,398 - Szeto , et al. June 8, 2	2010-06-08
Methods for preventing or treating ischemia-reperfusion injury of the kidney Grant 7,718,620 - Szeto , et al. May 18, 2	2010-05-18
Methods for preventing mitochondrial permeability transition Grant 7,576,061 - Szeto , et al. August 18, 2	2009-08-18
Medicinal uses of mu-opioid receptor agonists Grant 7,498,297 - Szeto , et al. March 3, 2	2009-03-03
Methods For Preventing Mitochondrial Permeability Transition App 20070027087 - Szeto; Hazel H. ; et al.	2007-02-01
Medicinal Uses of Mu-Opioid Receptor Agonists App 20070027070 - Szeto; Hazel ; et al.	2007-02-01
Methods for preventing mitochondrial permeability transition App 20040248808 - Szeto, Hazel H. ; et al.	2004-12-09
Medicinal uses of mu-opioid receptor agonists App 20040029796 - Szeto, Hazel ; et al.	2004-02-12
Dermorphin analogs having pharmacological activity Grant 5,602,100 - Brown , et al. * February 11, 1	1997-02-11
Delta opioid receptor antagonists and their use as analgesic agents Grant 5,455,230 - Schiller October 3, 1	1995-10-03
Dermorphin analogs Grant 5,312,899 - Schiller May 17, 1	1994-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.